Clinical Efficacy Supporting the Role of Intraperitoneal Drug Delivery in the Primary Chemotherapeutic Management of Small-Volume Residual Advanced Ovarian Cancer-Reference-Cited by-同舟云学术

Clinical Efficacy Supporting the Role of Intraperitoneal Drug Delivery in the Primary Chemotherapeutic Management of Small-Volume Residual Advanced Ovarian Cancer

Published:2006-12 Issue: Volume:33 Page:3-7
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Markman Maurie

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference26 articles.

1. Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma;Green;Obstet Gynecol,1959

2. Intracavitary 5-fluorouracil in malignant effusions;Suhrland;Arch Intern Med,1965

3. Use of nitrogen mustard in treatment of serous effusions of neoplastic origin;Weisberger;JAMA,1955

4. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer;Dedrick;Cancer Treat Rep,1978

5. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration;Alberts;Semin Oncol,1985

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Biodistribution of Expansile Nanoparticles: Intraperitoneal Administration Results in Tumor Specific Accumulation;ACS Nano;2023-01-26

2. Overview of Ovarian Cancer Chemotherapy;Advances in Diagnosis and Management of Ovarian Cancer;2022

3. Helical Tomotherapy versus Conventional Radiation to Deliver Abdominopelvic Radiation;Technology in Cancer Research & Treatment;2012-02

4. Gynecologic Cancer;Stereotactic Body Radiation Therapy;2011

5. Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus;Gynecologic Oncology;2008-12